These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8547205)

  • 1. Electropharmacology of the bradycardic agents alinidine and zatebradine (UL-FS 49) in a conscious canine ventricular arrhythmia model of permanent coronary artery occlusion.
    Aidonidis I; Brachmann J; Rizos I; Zacharoulis A; Stavridis I; Toutouzas P; Kübler W
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):555-63. PubMed ID: 8547205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alinidine reduces the incidence of ischemic ventricular fibrillation in a conscious canine model, a protective effect antagonized by overdrive atrial pacing.
    Uprichard AC; Chi LG; Lynch JJ; Driscoll EM; Frye JW; Lucchesi BR
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):475-82. PubMed ID: 2476629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac electrophysiologic effects of alinidine, a specific bradycardic agent, in the conscious dog: plasma concentration-response relations.
    Boucher M; Chassaing C; Chapuy E
    J Cardiovasc Pharmacol; 1995 Feb; 25(2):229-33. PubMed ID: 7752648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zatebradine slows ectopic ventricular rhythms in canine heart 24 hours after coronary artery ligation.
    Lasker SM; Han D; Kline RP
    J Cardiovasc Pharmacol; 1997 May; 29(5):662-9. PubMed ID: 9213210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of alinidine on experimental cardiac arrhythmias.
    Harron DW; Allen JD; Wilson R; Shanks RG
    J Cardiovasc Pharmacol; 1982; 4(2):221-5. PubMed ID: 6175804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prenylamine and AQ-A 39 on reentrant ventricular arrhythmias induced during the late myocardial infarction period in conscious dogs.
    Aidonidis I; Egel E; Hilbel T; Kuebler W; Brachmann J
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):401-7. PubMed ID: 7504130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of SUN-1165, N-(2,6-dimethylphenyl)-8-pyrrolizidine acetamide hydrochloride hemihydrate, a new class I antiarrhythmic drug, on ventricular arrhythmias, intraventricular conduction, and the refractory period in canine myocardial infarction.
    Hashimoto H; Satoh N; Nakashima M
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):417-24. PubMed ID: 1378123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of zatebradine, a specific bradycardic agent, on ischemia-induced arrhythmias in anesthetized rabbits.
    Bril A; Forest MC; Cheval B; Landais L; Gout B
    Pharmacology; 1994 May; 48(5):308-19. PubMed ID: 8016191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in systemic haemodynamics, regional myocardial function and perfusion induced by alinidine in pigs with and without narrowed coronary arteries.
    Verdouw PD; Duncker DJ; Heere TJ; Saxena PR
    Eur Heart J; 1987 Dec; 8 Suppl L():43-52. PubMed ID: 3451882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against programmed electrical stimulation-induced ventricular tachycardia and sudden cardiac death by NE-10064, a class III antiarrhythmic drug.
    Black SC; Butterfield JL; Lucchesi BR
    J Cardiovasc Pharmacol; 1993 Dec; 22(6):810-8. PubMed ID: 7509898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of DPI 201-106, a novel cardiotonic agent, on hemodynamics, cardiac electrophysiology and arrhythmias induced by programmed ventricular stimulation in dogs with subacute myocardial infarction: a comparative study with dobutamine.
    Ozaki T; Uematsu T; Nagashima S; Nishimoto M; Nakashima M
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):478-87. PubMed ID: 1766473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of oxymatrine on arrhythmia in dogs with myocardial infarction].
    Zeng JX; Cao HY; Li Q; Xu Z; Guo ZB
    Zhongguo Yao Li Xue Bao; 1996 Jul; 17(4):379-82. PubMed ID: 9812730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ajmaline on sustained ventricular tachycardia induced by programmed electrical stimulation in conscious dogs after myocardial infarction.
    Todt H; Krumpl G; Zojer N; Krejcy K; Raberger G
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Sep; 348(3):290-7. PubMed ID: 7694159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cromakalim or glibenclamide on arrhythmias and dispersion of refractoriness in chronically infarcted in anesthetized dogs.
    D'Alonzo AJ; Sewter JC; Darbenzio RB; Hess TA
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):222-8. PubMed ID: 7477447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of zatebradine on cardiac conduction and repolarization.
    Sen L; Cui G; Zhou LM; Sakaguchi Y; Singh BN
    J Cardiovasc Pharmacol Ther; 2002 Jan; 7(1):29-38. PubMed ID: 12000976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac electrophysiological effects of falipamil in the conscious dog: comparison with alinidine.
    Boucher M; Chassaing C; Chapuy E
    Eur J Pharmacol; 1996 Jun; 306(1-3):93-8. PubMed ID: 8813620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects on atrio-ventricular conduction of alinidine and falipamil injected into the AV node artery of the anesthetized dog.
    Takeda M; Furukawa Y; Ogiwara Y; Saegusa K; Haniuda M; Akahane K; Chiba S
    Arch Int Pharmacodyn Ther; 1989; 297():39-48. PubMed ID: 2730241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmed electrical stimulation after myocardial infarction and reperfusion in conscious dogs.
    Krumpl G; Todt H; Schunder-Tatzber S; Raberger G
    J Pharmacol Methods; 1990 Apr; 23(2):155-69. PubMed ID: 2332981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of zatebradine on contractility, relaxation and coronary blood flow.
    Breall JA; Watanabe J; Grossman W
    J Am Coll Cardiol; 1993 Feb; 21(2):471-7. PubMed ID: 8426013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of lethal ischemic ventricular arrhythmias by the class III agent E4031 in a canine model of previous myocardial infarction.
    Lynch JJ; Heaney LA; Wallace AA; Gehret JR; Selnick HG; Stein RB
    J Cardiovasc Pharmacol; 1990 May; 15(5):764-75. PubMed ID: 1692937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.